American Psychiatric Association Practice Guideline for the Prevention and Treatment of Delirium
American Psychiatric Association Publishing (Verlag)
978-0-89042-803-0 (ISBN)
Prevention, early detection, and optimal treatment are critical because delirium is often unrecognized and is associated with increased morbidity and mortality. For example, postsurgical delirium has been reported to have a 30-day mortality rate of up to 10%, versus 1% in postsurgical patients without delirium. Additionally, delirium exacts a significant economic toll on individuals, their families, and society because of longer hospital stays, ICU admissions, rehospitalizations, and lost wages. In the United States, direct health care costs of hospitalized older adults with delirium are significantly higher than hospitalized patients without delirium, even after adjusting for demographic and clinical factors.
The American Psychiatric Association Practice Guideline for the Prevention and Treatment of Delirium reviews current evidence-based nonpharmacological and pharmacological interventions to prevent or treat delirium in adults. In addition, it includes statements related to assessment and treatment planning, which are an integral part of patient-centered care. The guideline describes approaches to implementing recommendations and suggestions in clinical practice. By providing up-to-date knowledge, the guideline aims to help clinicians feel more confident in preventing, recognizing, and treating delirium, thereby improving the care and well-being of their patients.
Evidence tables, literature search results, clinical questions, and more for this guideline can be found in the online appendixes.
Guideline Writing Group, Systematic Review Group, Committee on Practice Guidelines, APA Assembly Liaisons, Table of Contents, Acronyms/Abbreviations, Introduction, Guideline Statement Summary, Guideline Statements and Implementation, Nonpharmacological Interventions, Pharmacological Interventions, Areas for Further Research, Guideline Development Process, References, Disclosures, Individuals and Organizations That Submitted Comments, Appendices (See Supplemental Material), Appendix A. Clinical Questions, Appendix B. Search Strategies, Study Selection, and Search Results, Appendix C. Review of Research Evidence Supporting Guideline Statements, Appendix D. Evidence Tables for Individual Studies Supporting Guideline Statements, Appendix E. Risk of Bias Ratings for Individual Studies Supporting Guideline Statements, Appendix F. Review of Benefits and Harms, Patient Preferences, and Other Practice Guidelines, Appendix G. Description of Additional Studies Reviewed, Appendix H. Evidence Tables for Additional Studies Reviewed, Appendix I. Considerations in the Use of Guidelines to Enhance the Quality of Care References
| Erscheinungsdatum | 05.11.2025 |
|---|---|
| Zusatzinfo | 10 Tables, unspecified |
| Verlagsort | VA |
| Sprache | englisch |
| Maße | 216 x 279 mm |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie |
| ISBN-10 | 0-89042-803-4 / 0890428034 |
| ISBN-13 | 978-0-89042-803-0 / 9780890428030 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
